Insider Transactions in Q3 2022 at Unitedhealth Group Inc (UNH)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 20
2022
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
108
+0.14%
|
-
|
Sep 20
2022
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.15%
|
-
|
Sep 20
2022
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.06%
|
-
|
Sep 20
2022
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.04%
|
-
|
Sep 20
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.33%
|
-
|
Sep 20
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.31%
|
-
|
Sep 20
2022
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
58
+0.12%
|
-
|
Sep 20
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.32%
|
-
|
Sep 20
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.14%
|
-
|
Sep 20
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
108
+0.29%
|
-
|
Sep 20
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.0%
|
-
|
Sep 20
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.04%
|
-
|
Sep 20
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.26%
|
-
|
Sep 20
2022
|
Rupert M Bondy EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.3%
|
-
|
Aug 26
2022
|
Thomas E Roos Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
465
-1.32%
|
$252,030
$542.37 P/Share
|
Aug 26
2022
|
Thomas E Roos Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
465
-1.3%
|
-
|
Aug 18
2022
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Open market or private sale
|
Direct |
14,715
-22.7%
|
$7,990,245
$543.32 P/Share
|
Aug 12
2022
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-0.98%
|
$133,578
$543.7 P/Share
|
Jul 29
2022
|
John F Rex President & CFO |
SELL
Open market or private sale
|
Direct |
13,183
-8.52%
|
$7,132,003
$541.53 P/Share
|
Jul 29
2022
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,982
-13.9%
|
$13,465,298
$539.37 P/Share
|
Jul 29
2022
|
John F Rex President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,757
+19.94%
|
$3,132,990
$70.24 P/Share
|
Jul 26
2022
|
Stephen J Hemsley Director |
SELL
Open market or private sale
|
Direct |
99,312
-11.2%
|
$53,032,608
$534.27 P/Share
|
Jul 26
2022
|
Stephen J Hemsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
99,312
+10.07%
|
$5,660,784
$57.38 P/Share
|
Jul 18
2022
|
Andrew Witty CEO, UHG |
SELL
Open market or private sale
|
Direct |
11,376
-12.94%
|
$5,995,152
$527.9 P/Share
|
Jul 01
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+2.01%
|
-
|
Jul 01
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.93%
|
-
|
Jul 01
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+0.04%
|
-
|
Jul 01
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.27%
|
-
|
Jul 01
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
172
+1.49%
|
-
|
Jul 01
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+2.09%
|
-
|
Jul 01
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+4.56%
|
-
|